共 375 条
[1]
Alter MJ(2007)Epidemiology of hepatitis C virus infection World J Gastroenterol 13 2436-2441
[2]
Manns MP(2001)Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial Lancet 358 958-965
[3]
McHutchison JG(2002)Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection N Engl J Med 347 975-978
[4]
Gordon SC(2007)Host and viral factors contributing to CD8+ T cell failure in hepatitis C virus infection World J Gastroenterol 13 4839-4847
[5]
Rustgi VK(2007)Impact of serum levels and gene polymorphism of cytokines on chronic hepatitis C infection Transl Res 150 116-121
[6]
Shiffman M(2009)Metabolic Syndrome, Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus: Impact on Disease Progression and Treatment Response Liver Int 29 3-12
[7]
Reindollar R(2007)Sustained virologic response to therapy of recurrent hepatitis C after liver transplantation is related to early virologic response and dose adherence Liver Transpl 13 1100-1108
[8]
Goodman ZD(2009)Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance Nature 461 399-401
[9]
Koury K(2009)Genetic variation in IL28B and spontaneous clearance of hepatitis C virus Nature 461 798-801
[10]
Ling M(2010)Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus Gastroenterology 139 120-9